These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 16247094

  • 21. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):752-5. PubMed ID: 16139120
    [Abstract] [Full Text] [Related]

  • 22. [Secondary prevention after stroke. Doubled performs better].
    MMW Fortschr Med; 2003 Nov 13; 145(46):49. PubMed ID: 14699837
    [No Abstract] [Full Text] [Related]

  • 23. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS, Skalabrin EJ, Kraiss LW.
    Am J Ther; 2009 Nov 13; 16(2):164-70. PubMed ID: 19300042
    [Abstract] [Full Text] [Related]

  • 24. [Platelet-function inhibitors in the secondary prevention of ischemic stroke].
    Busse O, Diener HC, Grond M.
    Dtsch Med Wochenschr; 2006 Nov 13; 131 Suppl 5():S132-4. PubMed ID: 17089258
    [No Abstract] [Full Text] [Related]

  • 25. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb 13; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 26. MATCH results: implications for the internist.
    Lutsep HL.
    Am J Med; 2006 Jun 13; 119(6):526.e1-7. PubMed ID: 16750967
    [Abstract] [Full Text] [Related]

  • 27. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
    Lutsep HL.
    J Stroke Cerebrovasc Dis; 2007 Jun 13; 16(6):263-7. PubMed ID: 18035244
    [Abstract] [Full Text] [Related]

  • 28. The effect of a slower than standard dose escalation scheme for dipyridamole on headaches in secondary prevention therapy of strokes: a randomized, open-label trial (DOSE).
    de Vos-Koppelaar NC, Kerkhoff H, de Vogel EM, Zock E, Dieleman HG.
    Cerebrovasc Dis; 2014 Jun 13; 37(4):285-9. PubMed ID: 24819911
    [Abstract] [Full Text] [Related]

  • 29. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack.
    Hills NK, Johnston SC.
    Stroke; 2008 Apr 13; 39(4):1228-32. PubMed ID: 18323509
    [Abstract] [Full Text] [Related]

  • 30. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC.
    Int J Stroke; 2006 Feb 13; 1(1):4-8. PubMed ID: 18706062
    [Abstract] [Full Text] [Related]

  • 31. Use of dipyridamole in patients with recent stroke or TIA.
    Bernstein RA.
    Am Fam Physician; 2005 Aug 01; 72(3):382, 384; author reply 384. PubMed ID: 16100852
    [No Abstract] [Full Text] [Related]

  • 32. Aggrenox: a combination of antiplatelet drugs for stroke prevention.
    Med Lett Drugs Ther; 2000 Feb 07; 42(1071):11-2. PubMed ID: 10725967
    [No Abstract] [Full Text] [Related]

  • 33. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
    Offerhaus L.
    Ned Tijdschr Geneeskd; 2006 Dec 02; 150(48):2673; author reply 2673-4. PubMed ID: 17205947
    [No Abstract] [Full Text] [Related]

  • 34. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA, Tobin WO, Cox D, Coughlan T, Collins R, O'Neill D, Murphy RP, McCabe DJ.
    J Stroke Cerebrovasc Dis; 2013 Oct 02; 22(7):e84-92. PubMed ID: 22981273
    [Abstract] [Full Text] [Related]

  • 35. Is acetylsalicylic acid plus dipyridamole superior to ASA alone for secondary prevention of stroke?
    Dalton B, Papoushek C, Evans MF.
    Can Fam Physician; 2001 Nov 02; 47():2235-9. PubMed ID: 11768921
    [No Abstract] [Full Text] [Related]

  • 36. Clinical inquiries. What is the best management for patients who have a TIA while on aspirin therapy?
    Ahmed N, Coffey JB, Oh R.
    J Fam Pract; 2006 Jul 02; 55(7):627-8. PubMed ID: 16822451
    [Abstract] [Full Text] [Related]

  • 37. New insights in antiplatelet therapy for patients with ischemic stroke.
    Chaturvedi S, Bhattacharya P.
    Neurologist; 2011 Sep 02; 17(5):255-62. PubMed ID: 21881467
    [Abstract] [Full Text] [Related]

  • 38. Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoring.
    Macdonald S.
    Eur J Vasc Endovasc Surg; 2007 Aug 02; 34(2):143-4. PubMed ID: 17588786
    [No Abstract] [Full Text] [Related]

  • 39. Antiplatelet agents for stroke prevention following transient ischemic attack.
    Weinberger J.
    South Med J; 2008 Jan 02; 101(1):70-8. PubMed ID: 18176296
    [Abstract] [Full Text] [Related]

  • 40. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
    Aw D, Sharma JC.
    Postgrad Med J; 2012 Jan 02; 88(1035):34-7. PubMed ID: 22121248
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.